GPR35 antagonist CID-2745687 attenuates anchorage-independent cell growth by inhibiting YAP/TAZ activity in colorectal cancer cells
Background and purpose: GPR35, a member of the orphan G-protein-coupled receptor, was recently implicated in colorectal cancer (CRC). However, whether targeting GPR35 by antagonists can inhibit its pro-cancer role has yet to be answered.Experimental approach: We applied antagonist CID-2745687 (CID)...
Saved in:
Main Authors: | Wuxiyar Otkur (Author), Xiaolong Liu (Author), Huan Chen (Author), Siyi Li (Author), Ting Ling (Author), Hanchen Lin (Author), Renyu Yang (Author), Tian Xia (Author), Huan Qi (Author), Hai-Long Piao (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An engineered mayhem: YAP/TAZ mechanosignaling and hepatocarcinogenesis in NAFLD
by: Gyorgy Baffy
Published: (2021) -
Deubiquitinase JOSD2 stabilizes YAP/TAZ to promote cholangiocarcinoma progression
by: Meijia Qian, et al.
Published: (2021) -
Cinobufacini injection suppresses the proliferation of human osteosarcoma cells by inhibiting PIN1-YAP/TAZ signaling pathway
by: Yuru Chen, et al.
Published: (2023) -
Natural compounds targeting YAP/TAZ axis in cancer: Current state of art and challenges
by: Aviral Kumar, et al.
Published: (2024) -
Direct YAP/TAZ-TEAD inhibitor paves the way toward realizing cancer mechanomedicine
by: Kostas A. Papavassiliou, et al.
Published: (2024)